Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketocaine
- Development stage
- Discontinued
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Ketocaine (INN; brand name Vericaina) is an amino ether local anesthetic belonging to the butyrophenone family. It is primarily used topically for pain relief and is marketed in Italy. Historically, it has been investigated for local anesthesia in procedures like cutting split skin grafts, for pain relief in labor, and for referred pain in primary dysmenorrhea. In preclinical studies, Ketocaine has also shown potential antitumor activity. Its mechanism of action involves inducing local anesthesia.
- Brand names
- Vericaina
- Other names
- KetocainumketocainaWA1RT89G9XWA-1RT89G9XWA 1RT89G9X1-[2-[2-[di(propan-2-yl)amino]ethoxy]phenyl]butan-1-oneChetocainaCetocaina1092-46-2
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Ketocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ketocaine.